Midazolam-fentanyl analgo-sedation in pediatric dental patients--a pilot study

Area of Science:

• Pediatric Anesthesiology
• Pharmacology
• Pain Management

Background:

• Procedural sedation in children often requires effective pharmacologic agents.
• Oral midazolam is commonly used but may have limitations in efficacy for longer procedures.
• Submucosal fentanyl offers a potential adjunct for enhanced sedation and analgesia.

Purpose of the Study:

• To compare the effectiveness of submucosal fentanyl with oral midazolam versus oral midazolam alone for pediatric procedural sedation.
• To assess the efficacy and safety of combined submucosal fentanyl and oral midazolam in uncooperative children undergoing dental procedures.

Main Methods:

• A triple-blind, randomized, two-stage crossover study involving 23 uncooperative pediatric patients (ASA type I).
• Participants received either submucosal fentanyl (3 mcg/kg) or placebo, alongside oral midazolam (0.5 mg/kg).
• Each child received both treatment regimens sequentially.

Main Results:

• The combination of oral midazolam and submucosal fentanyl resulted in a 73.91% success rate, compared to 47.83% for oral midazolam with placebo.
• Children receiving submucosal fentanyl were 2.8 times more likely to have a satisfactory 45-minute dental procedure.
• Four children experienced transient oxygen desaturation with the submucosal fentanyl regimen.

Conclusions:

• Submucosal fentanyl enhances the working time and effectiveness of oral midazolam for pediatric procedural sedation.
• The observed oxygen desaturation necessitates further research into lower doses for safe routine use.
• Further studies are required to optimize the combination for pediatric procedural sedation and analgesia.